Brief: Median Technologies Announces Pivotal Reality Study Of Its Eyonis™ Lcs Lung Cancer Diagnostic Met All Primary And Secondary Endpoints

Median Technologies SA

29/08/2024 20:42

Aug 29 (Reuters) - Median Technologies SA  ALMDT.PA :
    * MEDIAN TECHNOLOGIES ANNOUNCES PIVOTAL REALITY STUDY OF ITS
EYONIS™ LCS LUNG CANCER DIAGNOSTIC MET ALL PRIMARY AND SECONDARY
ENDPOINTS
    * MEDIAN TECHNOLOGIES: U.S. & EUROPEAN EYONIS LCS MARKETING
AUTHORIZATION REGULATORY FILINGS IN H1 2025
    * MEDIAN TECHNOLOGIES SA: RELIVE SECOND EYONIS™ LCS PIVOTAL
STUDY,
TO REPORT TOP-LINE DATA IN Q1 2025

Source text for Eikon:  ID:nBw3MPtjxa 
Further company coverage:  ALMDT.PA 

 ((Reuters.Briefs@thomsonreuters.com;))